Breaking News

Tag Archives: Irilone as a progesterone receptor (PR) effect supporter in endometrial and ovarian cancer cell lines

Irilone as a progesterone receptor (PR) effect supporter in endometrial and ovarian cancer cell lines

Dr. Mehdi Nabati Iranian Drug Designer

Irilone as a progesterone receptor (PR) effect supporter in endometrial and ovarian cancer cell lines   Estrogen and Progesterone receptors (ER, PR) are ligand-induced transcription factor members of the steroid hormone receptor (SR) subfamily of nuclear receptors. Those receptors and their corresponding steroid hormones (estradiol and progesterone) play their roles …

Read More »